William J Sandborn Selected Research

Colectomy

10/2021	Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.
10/2021	Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
1/2021	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
1/2021	Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
1/2018	Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
1/2018	Efficacy and Safety of Endoscopic Balloon Dilatation of Ileoanal Pouch Strictures.
5/2017	Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
1/2016	Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States.
5/2015	Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials.
8/2013	Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William J Sandborn Research Topics

Disease

238	Crohn Disease (Crohn's Disease) 11/2022 - 01/2002
201	Ulcerative Colitis 10/2022 - 04/2002
118	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 01/2002
51	Infections 11/2022 - 12/2002
31	Inflammation (Inflammations) 06/2022 - 05/2002
29	Necrosis 01/2022 - 02/2003
26	Neoplasms (Cancer) 01/2022 - 04/2002
25	Hemorrhage 01/2022 - 12/2005
14	Colitis 01/2022 - 04/2002
14	Body Weight (Weight, Body) 01/2021 - 11/2004
13	Fistula 01/2019 - 09/2002
12	Rheumatoid Arthritis 01/2022 - 05/2002
9	Ulcer 11/2022 - 04/2012
9	Pouchitis 01/2022 - 04/2002
9	Delayed Hypersensitivity (Hypersensitivity, Type IV) 05/2010 - 05/2002
8	Diarrhea 12/2019 - 11/2002
7	Proctitis 11/2022 - 05/2012
7	Abdominal Pain (Pain, Abdominal) 10/2022 - 08/2013
7	Skin Neoplasms (Skin Cancer) 01/2022 - 04/2014
7	Herpes Zoster 01/2022 - 10/2009
7	Obesity 01/2021 - 01/2017
7	Colorectal Neoplasms (Colorectal Cancer) 05/2017 - 01/2006
6	Pathologic Constriction (Stenosis) 01/2022 - 05/2004
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2015
6	Tuberculosis (Tuberculoses) 01/2014 - 12/2002
5	Sepsis (Septicemia) 08/2022 - 04/2009
5	Opportunistic Infections (Opportunistic Infection) 01/2019 - 04/2008
5	Abscess 01/2019 - 01/2009
5	Disease Progression 01/2016 - 02/2006
5	Lymphoma (Lymphomas) 06/2013 - 01/2002
5	Demyelinating Diseases (Demyelinating Disease) 09/2011 - 12/2003
4	Injection Site Reaction 01/2022 - 02/2006
4	Hypersensitivity (Allergy) 01/2019 - 10/2004
4	Leukopenia 01/2018 - 07/2003
4	Multiple Sclerosis 01/2018 - 01/2004
4	Weight Loss (Weight Reduction) 01/2018 - 11/2002
4	Microscopic Colitis 02/2013 - 01/2006
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
3	Arthralgia (Joint Pain) 01/2022 - 02/2006
3	Psoriatic Arthritis 01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

75	Infliximab (Remicade)FDA Link 12/2021 - 05/2002
59	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2002
49	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 08/2002
45	vedolizumabIBA 01/2022 - 01/2004
43	Pharmaceutical PreparationsIBA 11/2022 - 11/2002
42	Adalimumab (Humira)FDA Link 11/2022 - 02/2003
39	Monoclonal AntibodiesIBA 01/2022 - 05/2002
38	Biological ProductsIBA 11/2022 - 05/2002
32	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2004
30	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 01/2002
29	C-Reactive ProteinIBA 10/2022 - 12/2003
27	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2003
25	Certolizumab Pegol FDA Link 01/2022 - 02/2003
25	tofacitinibIBA 01/2022 - 08/2012
24	Azathioprine (Imuran)FDA LinkGeneric 07/2022 - 01/2002
21	Ustekinumab (CNTO 1275)FDA Link 11/2022 - 10/2008
20	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 12/2003
18	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022 - 11/2008
17	IntegrinsIBA 07/2022 - 11/2003
17	SteroidsIBA 01/2020 - 09/2002
17	Budesonide (Pulmicort)FDA LinkGeneric 12/2017 - 01/2002
15	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2022 - 01/2002
15	Janus Kinase InhibitorsIBA 01/2022 - 08/2012
14	golimumab FDA Link 01/2021 - 01/2014
13	Immunologic Factors (Immunomodulators)IBA 01/2022 - 12/2008
13	AntibodiesIBA 11/2021 - 02/2003
11	Interleukin-12 (IL 12)IBA 01/2020 - 05/2002
10	CytokinesIBA 01/2022 - 05/2002
10	Interleukin-23 (Interleukin 23)IBA 01/2022 - 10/2008
8	Natalizumab (Tysabri)FDA Link 01/2018 - 05/2002
7	ozanimodIBA 01/2022 - 01/2016
7	Phenobarbital (Luminal)FDA Link 01/2022 - 05/2006
6	InterleukinsIBA 07/2022 - 03/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2007
6	risankizumabIBA 01/2022 - 01/2017
6	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2002
5	ontamalimabIBA 01/2022 - 01/2017
5	AlbuminsIBA 01/2021 - 01/2013
5	Serum AlbuminIBA 01/2020 - 04/2012
5	LactoferrinIBA 01/2020 - 06/2003
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 04/2010 - 01/2002
4	Janus Kinase 1IBA 01/2022 - 01/2020
4	etrolizumabIBA 01/2022 - 07/2014
4	upadacitinibIBA 01/2022 - 01/2020
4	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 08/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2002
4	Prednisone (Sone)FDA LinkGeneric 12/2017 - 05/2006
4	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2015 - 01/2009
4	recombinant human tumor necrosis factor-binding protein-1IBA 07/2006 - 05/2002
4	Etanercept (Enbrel)FDA Link 01/2005 - 05/2002
3	mirikizumabIBA 01/2022 - 01/2020
3	Opiate AlkaloidsIBA 01/2022 - 01/2021

Therapy/Procedure

205	Therapeutics 11/2022 - 01/2002
29	Biological Therapy 05/2022 - 05/2002
17	Colectomy 10/2021 - 04/2002
14	Remission Induction 01/2020 - 01/2002
9	Restorative Proctocolectomy 01/2022 - 09/2002
6	Aftercare (After-Treatment) 01/2022 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 12/2005
4	Blood Component Removal (Apheresis) 08/2008 - 12/2005